Crossmark

Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

Crossref DOI link: https://doi.org/10.1016/j.medcle.2019.10.005

Published Print: 2020-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Hernández-Rivas, José-Ángel

Gironella Mesa, Mercedes
Funding

Funding for this research was provided by:

Takeda Farmacéutica España

logistic and coordination

Real World Insights team of IQVIA España
License Information

Text and Data Mining valid from 2020-04-01
More Information

This article is maintained by: Elsevier

Article Title: Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2019.10.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2019.10.006

Content Type: article

Copyright: © 2019 The Author(s). Published by Elsevier España, S.L.U.